R. Mitchell

发表

Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: a reexamination.

A. Weetman, W. Robertson, C. Wardle, 1993, The Journal of clinical endocrinology and metabolism.

Differences in Serum Luteinizing Hormone Measurements by Immunoradiometric Assay Induced by Kinetic Manipulation of Assay Conditions are Dependent on the Endocrine Milieu of Serum

I. Laing, A. Olukoga, W. Robertson, 1996, Annals of clinical biochemistry.

The effect of some antiprostatic steroids upon cortisol production by guinea-pig adrenal cells stimulated by ACTH.

W. Robertson, A. Lambert, V. Petrow, 1989, Biochemical pharmacology.

Some characteristics of human adrenal microsomal 21-hydroxylase activity.

D. Anderson, W. Robertson, R. Mitchell, 1985, Journal of steroid biochemistry.

Effect of propofol, thiopentone and etomidate on adrenal steroidogenesis in vitro.

W. Robertson, A. Lambert, R. Mitchell, 1985, British journal of anaesthesia.

Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.

S. Shalet, S. Shalet, E. Crowne, 1995, The Journal of clinical endocrinology and metabolism.

An investigation of LH pulsatility in burned men by bioassay and radioimmunoassay.

W. Robertson, C. Semple, R. Mitchell, 1992, Acta endocrinologica.

Mechanisms leading to hypogonadism in men with burns injuries.

D. Gordon, G. Beastall, W. Robertson, 1987, British medical journal.

W. Robertson, R. Mitchell, Sally Hollls, 1995, Clinical endocrinology.

Effect of low dose oxandrolone and testosterone treatment on the pituitary‐testicular and GH axes in boys with constitutional delay of growth and puberty

J. Holly, S. Shalet, S. Shalet, 1997, Clinical endocrinology.

DIRECT IN VITRO INHIBITION OF ADRENAL STEROIDOGENESIS BY ETOMIDATE

J. Ratcliffe, J. Frost, W. Robertson, 1983, The Lancet.

Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon, Org 32489): a comparison with Metrodin and Metrodin-HP.

W. Robertson, A. Lambert, J. McLoughlin, 1996, Molecular human reproduction.

The effect of ketoconazole on adrenal and testicular steroidogenesis in vitro.

W. Robertson, A. Lambert, R. Mitchell, 1986, Biochemical pharmacology.

ON THE SITE OF ACTION OF THE ANTI‐ADRENAL STEROIDOGENIC EFFECT OF ETOMIDATE AND MEGESTROL ACETATE

J. Frost, W. Robertson, A. Lambert, 1984, Clinical endocrinology.

A simple in vitro approach to the estimation of the biopotency of drugs affecting adrenal steroidogenesis.

J. Frost, W. Robertson, A. Lambert, 1985, Journal of steroid biochemistry.

The bioavailability and metabolism of trilostane in normal subjects, a comparative study using high pressure liquid chromatographic and quantitative cytochemical assays.

W. Robertson, D. T. Robinson, R. Mitchell, 1984, Journal of steroid biochemistry.

A CYTOCHEMICAL SECTION BIOASSAY FOR PLASMA TRILOSTANE: AN ORALLY ACTIVE INHIBITOR OF 3β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY

W. Robertson, R. Mitchell, R. Earnshaw, 1984, Clinical endocrinology.

Human chorionic gonadotrophin contributes to the bioactivity of Pergonal

W. Robertson, A. Lambert, R. Mitchell, 1992, Clinical endocrinology.

Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment

K. Schärer, F. Schaefer, W. Robertson, 1994, Clinical endocrinology.

Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations.

W. Robertson, V. Crowley, J. McLoughlin, 1995, Clinical chemistry.

Recombinant human luteinizing hormone: a partial physicochemical, biological and immunological characterization.

W. Robertson, J. Talbot, A. Lambert, 1996, Molecular human reproduction.

Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).

H. Burger, W. Robertson, P. Matson, 1996, Human reproduction.

Recombinant hormones: In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin—HP

W. Robertson, A. Lambert, C. Wardle, 1995 .

In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP.

W. Robertson, A. Lambert, C. Wardle, 1995, Human reproduction.

Pulsatile immunoreactive and bioactive luteinizing hormone secretion in adolescents with chronic renal failure

K. Schärer, F. Schaefer, W. Robertson, 1991, Pediatric Nephrology.

Elevated serum immunoreactive inhibin levels in peripubertal boys with chronic renal failure

K. Schärer, F. Schaefer, W. Robertson, 1993, Clinical endocrinology.

Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease

P. Kendall‐Taylor, W. Robertson, A. Lambert, 1988, British medical journal.

On the site of action of the anti-adrenal steroidogenic effect of cyproterone acetate.

W. Robertson, A. Lambert, R. Mitchell, 1985, Biochemical pharmacology.

On the Assessment of the in Vitro Biopotency and Site(s) of Action of Drugs Affecting Adrenal Steroidogenesis

J. Frost, W. Robertson, A. Lambert, 1986, Annals of clinical biochemistry.

ACTH Adrenal Cell Bioassay: Improved Sensitivity (12 ng/L) Achieved by Immunoextraction of Acth from Human Plasma by a Monoclonal Antibody

A. White, W. Robertson, A. Lambert, 1990, Annals of Clinical Biochemistry.

On the biopotency and site of action of drugs affecting endocrine tissues with special reference to the anti-steroidogenic effect of anaesthetic agents.

J. Frost, W. Robertson, A. Lambert, 1985, Postgraduate medical journal.